Browsing by Keyword : Omalizumab
Showing results 1 to 10 of 10
| Pub Year | | Title | AJOU Author(s) |
| 2022 | | Association of chronic spontaneous urticaria with the first exposure to general anaesthesia | 김진철, 이은소, 최지웅 |
| 2022 | | Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy | 박해심, 유민숙 |
| 2020 | | Current and Future Treatments of Rhinitis and Sinusitis | 박해심 |
| 2021 | | Effect of omalizumab as add-on therapy to quality of life questionnaire for korean asthmatics (Kaqlq) in korean patients with severe persistent allergic asthma | 박해심 |
| 2024 | | Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials | 예영민 |
| 2017 | | Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria | 박해심, 예영민 |
| 2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
| 2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
| 2018 | | Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea | 남동호, 박해심, 신유섭, 예영민 |
| 2023 | | Treatment with biological products for chronic urticaria | 예영민 |
1
